From longevity to biotech: What's next for US skin care?

Published: 23-Apr-2025

Dr Katerina Steventon talks healthy ageing, prevention, biotech and more with Dermalogica’s Dr Robert J Bianchini

You need to be a subscriber to read this article.
Click here to find out more.

The Anti-Ageing Skin Care Conference has been a leading forum for advancing science and innovation in this industry category since 2008. As we look ahead to the next event in 2026, this column will continue the dialogue.

Dr Katerina Steventon, the Scientific Programme Director of the Anti-Ageing Skin Care Conference, interviews Dr Robert J Bianchini, Vice-President of Technology and Development at Dermalogica – a Unilever Prestige Company.

How will the anti-ageing space, even if it may not be called that any more, evolve?

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like